Special Issue "HIV Vaccines"
Deadline for manuscript submissions: closed (30 September 2018) | Viewed by 29648
Interests: HIV; Env conformation; neutralizing and non-neutralizing Abs; ADCC; small molecule entry inhibitors; HIV accessory proteins; CD4; neutralization
Special Issues, Collections and Topics in MDPI journals
The development of a safe and effective HIV vaccine remains a critical unmet goal in the fight against the HIV pandemic. HIV envelope glycoproteins (Env) are the only virus-specific proteins on the viral surface and serve as a target for host neutralizing and non-neutralizing antibodies. A major hurdle to target Env is its variability and conformational flexibility. Recent advances in understanding Env conformational dynamics in combination with new Env structural information are providing critical information required to develop effective immunogens. These new insights in combination with a better understanding of correlates of protection, including the protective role of Fc-mediated effector functions, are greatly helping move the field forward.
In this Special Issue, we welcome the HIV vaccine community to submit research papers or review articles related to all aspects of HIV vaccine research, which will help provide a comprehensive view of this rapidly-evolving field. Topics may include (but are not limited to) Env conformation, immunogen design, neutralizing and non-neutralizing antibodies, Fc-mediated effector functions and additional immune correlates of protection.
Prof. Andrés Finzi
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- neutralizing antibodies
- non-neutralizing antibodies
- immune correlates of protection